Dr. Hoffman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Durham VA Medical Centr, 508 Fulton St
Pathology & Lab Medicine Service (113)
Durham, NC 27705Phone+1 919-286-6994Fax+1 919-286-6818
Summary
- I am a physician-scientist and board certified pathologist specializing in the pharmacologic and transfusion management of bleeding and thrombotic disorders
Education & Training
Duke University HospitalResidency, Pathology-Anatomic and Clinical, 1982 - 1985
University of Iowa Roy J. and Lucille A. Carver College of MedicineClass of 1982
Certifications & Licensure
NC State Medical License 1983 - 2025
FL State Medical License 1986 - 1987- American Board of Pathology Anatomic Pathology & Clinical Pathology
Publications & Presentations
PubMed
- 337 citationsCoagulation disorders and hemostasis in liver disease: Pathophysiology and critical assessment of current managementStephen H. Caldwell, Maureane Hoffman, Ton Lisman, B. Gail Macik, Patrick G. Northup
Hepatology. 2006-10-01 - 9 citationsNanosilver composite pNIPAm microgels for the development of antimicrobial platelet-like particles.Eunice Chee, Seema Nandi, Kimberly Nellenbach, Emily Mihalko, Douglas B. Snider
Journal of Biomedical Materials Research. Part B, Applied Biomaterials. 2020-02-26 - 8 citationsThrombin generation and implications for hemophilia therapies: A narrative review.Robert F Sidonio Jr, Maureane Hoffman, Gili Kenet, Yesim Dargaud
Research and Practice in Thrombosis and Haemostasis. 2023-01-01
Abstracts/Posters
- Characterization of a Novel Human Factor VIIa Chimera with Increased Tissue Factor-Independent Activity for Emergency HemostasisMaureane Hoffman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Lectures
- Biochemical Characteristics of Emicizumab Activity with Factors IXa, X, and VIIa2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Other
- Therapeutic uses of recombinant coagulation factor VIIaHoffman M
http://www.uptodate.com/contents/therapeutic-uses-of-recombinant-coagulation-factor-viia
UpToDate, Wolters Kluwer Health - 2012-09-19
Professional Memberships
- Member
- Member
- Member
- American Association of Blood BanksMember
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
